Comparison of two models of cancer risk estimation: A statistical analysis

European Journal of Oncology

Volumn 11, Issue 3, 2006, Pages 165-176

  Baker, Gizelle S ^a   Nakamura, Tsuyoshi ^b   Hoel, David G ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Cancer; Gamma rays; Mouse; Neutrons

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER MORTALITY; CANCER RISK; CARCINOGENESIS; COMPARATIVE STUDY; GAMMA IRRADIATION; MEDICAL RESEARCH; MOUSE; NEUTRON ACTIVATION ANALYSIS; NONHUMAN; RETICULOENDOTHELIAL SYSTEM; RISK ASSESSMENT; SOLID TUMOR;

EID: 33750578192     PISSN: 11286598     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. ICRP. The 1990 Recommendations of the International Commission on Radiological Protection. Publication 60. Annals of the ICRP, Vol. 21, no. 1-3. Oxford: Pergamon Press, 1990.
2. Carnes BA, Olshansky SJ, Grahn D. An interspecies prediction of the risk of radiation-induced mortality. Radiat Res 1998; 149: 487-92.
3. Hoel DG, Li P. Threshold models in radiation carcinogenesis. Health Physics 1998; 75: 241-50.
4. Kai M, Luebeck EG, Moolgavkar SH. Analysis of the incidence of solid cancer among atomic bomb survivors using a two-stage model of carcinogenesis. Radiat Res 1997; 148: 348-58.
5. Luebeck EG, Heidenreich WF, Hazelton WD, et al. Biologically based analysis of the data for the Colorado uranium miners cohort: age, dose and dose-rate effects. Radiat Res 1999; 152; 339-51.
6. Heidenreich WF, Brugmans MJ, Little MP, et al. Analysis of lung tumour risk in radon-exposed rats: an intercomparison of multi-step modelling. Radiat Environ Biophysics 2000; 39: 253-64.
7. Moolgavkar SH. Carcinogenesis modeling: from molecular biology to epidemiology. Ann Rev Public Health 1986; 7: 151-69.
8. Heidenreich WF, Luebeck EG, Moolgavkar SH. Some properties of the hazard function of the two-mutation clonal expansion model. Risk Analysis 1997; 17: 391-9.
9. Hanin LG, Yakovlev AY. A nonidentifiability aspect of the two-stage model of carcinogenesis. Risk Analysis 1996; 16: 711-5.
10. Grahn D, Lombard LS, Carnes BA. The comparative tumorigenic effects of fission neutrons and cobalt-60 gamma rays in the B6CF1 mouse. Radiat Res 1992; 129: 19-36.
11. Grahn D, Wright BJ, Carnes BA, et al. Studies of acute and chronic radiation injury at the biological and medical research Division, Argonne National Laboratory 1970-1992: the Janus program: survival and pathology data. ANL-95/3. Argonne, IL, 1995.
12. Carnes BA, Gavrilova N, Grahn D. Pathology effects at radiation doses below those causing increased mortality. Radiat Res 2002; 158: 187-94.
13. Cox DR. Regression models and life-tables. J R Statistical Society 1972; 34: 187-202.
14. Akaike H. An information criterion. Math Sci 1976; 1: 5-9.
15. Nakamura T, Hoel D. Comparing risks between radiation and dioxin exposure based on two-stage model. Environmetrics 2003; 14: 203-11.
16. Storer JB, Fry RJ. On the shape of neutron dose-effect curves for radiogenic cancers and life shortening in mice. Radiat Environ Biophysics 1995; 34: 21-7.
17. Carnes BA, Grahn D, Thomson JF. Dose-response modeling of life shortening in a retrospective analysis of the combined data from the Janus program at Argonne National Laboratory. Radiat Res 1989; 119: 39-56.
18. Thomson JF, Grahn D. Life shortening in mice exposed to fission neutrons and gamma rays. VII. Effects of 60 once-weekly exposures. Radiat Res 1988; 115: 347-60.
19. Thomson JF, Williamson FS, Grahn D. Life shortening in mice exposed to fission neutrons and gamma rays. V. Further studies with single low doses. Radiation Research 1985; 104: 420-8.
20. Committee on the Biological Effects of Ionizing Radiation, National Research Council. Health effects of exposure to low levels of ionizing radiation (BEIR V). Washington, DC: National Academy Press, 1990.
21. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and effects of ionizing radiation. 1994 report to the General Assembly, with scientific annexes. New York: United Nations, 1994.
22. Balcer-Kubiczek EK, Harrison GH, Torres BA, et al. Application of the constant exposure time technique to transformation experiments with fission neutrons: failure to demonstrate dose-rate dependence. Int J Radiat Biol 1994; 65: 559-69.
23. Brenner DJ, Hall EJ. Commentary to cox and little: radiation-induced oncogenic transformation: the interplay between dose, dose protraction, and radiation quality. Adv Radiat Biol 1992; 16: 167-79.
24. Carnes BA, Grahn D. Issues about neutron effects: the JANUS program. Radiat Res 1991; 128: S141-6.
25. ICRU. The quality factor in radiation protection. Report 40. Bethesda, MD: International Commission on Radiation Units and Measurement, 1986.
26. 60Co gamma rays. Nuclear Science Applications 1986; 2: 385-96.
27. Hill CK, Carnes BA, Han A, et al. Neoplastic transformation is enhanced by multiple low doses of fission-spectrum neutrons. Radiat Res 1985; 102: 404-10.
28. Howe GR. Lung cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with lung cancer mortality in the atomic bomb survivors study. Radiat Res 1995; 142: 295-304.
29. Pierce DA, Shimizu Y, Preston DL, et al. Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990. Radiat Res 1996; 146: 1-27.
30. Goddard MJ, Krewski D. The future of mechanistic research in risk assessment: where are we going and can we get there from here? Toxicology 1995; 102: 53-70.
31. Ward JF. Radiation mutagenesis: the initial Dna lesion is responsible. Radiat Res 1995; 142: 362-8.
32. Little JB. Radiation carcinogenesis. Carcinogenesis 2000; 21, 397-404.
33. Heidenreich WF, and Hoogenveen R. Limits of applicability for the deterministic approximation of the two-step clonal expansion model. Risk Analysis 2001; 21: 103-5.
34. Mothersill C, Seymour CB. Mechanisms and implications of genomic instability and other delayed effects of ionizing radiation exposure. Mutagenesis 1998; 13: 421-6.
35. Watson GE, Lorimore SA, Macdonald DA, et al. Chromosomal instability in unirradiated cells induced in vivo by a bystander effect of ionizing radiation. Cancer Res 2000; 60: 5608-11.
36. Lewis DA, Mayhugh BM, Qin Y, et al. Production of delayed death and neoplastic transformation in Cgl1 cells by radiation-induced bystander effects. Radiat Res 2001; 156: 251-8.
37. Kadhim MA, Marsden SJ, Malcolmson AM, et al. Long-term genomic instability in human lymphocytes induced by single-particle irradiation. Radiat Res 2001; 155: 122-6.
38. Little JB. Radiation-induced genomic instability. Int J Radiat Biol 1998; 74: 663-71.
39. Shimizu Y, Kato H, Schull WJ. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985. Part 2. Cancer mortality based on the recently revised doses (DS86). Radiat Res 1990; 121: 120-41.
40. Portier CJ. Statistical properties of a two-stage model of carcinogenesis. Environmental Health Perspectives 1987; 76: 125-31.